In the backdrop of the emergence of the Omicron variant of the Covid-19 virus, Professor Akiko Iwasaki explained how mucosal vaccines, administered via the nose, may be the answer. Speaking on Day 1 of the 19th edition of the Hindustan Times Leadership Summit, the Yale University immunobiologist revealed the progress on development of a nasal vaccine. Watch the full video for more.